...
首页> 外文期刊>Journal of nanoparticle research: An interdisciplinary forum for nanoscale science and technology >Biodegradable PLGA-b-PEG polymeric nanoparticles: Synthesis, properties, and nanomedical applications as drug delivery system
【24h】

Biodegradable PLGA-b-PEG polymeric nanoparticles: Synthesis, properties, and nanomedical applications as drug delivery system

机译:可生物降解的PLGA-b-PEG聚合物纳米颗粒:合成,性质和作为药物递送系统的纳米医学应用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

During the past decades many synthetic polymers have been studied for nanomedicine applications and in particular as drug delivery systems. For this purpose, polymers must be non-toxic, biodegradable, and biocompatible. Polylactic-co-glycolic acid (PLGA) is one of the most studied polymers due to its complete biodegradability and ability to self-assemble into nanometric micelles that are able to entrap small molecules like drugs and to release them into body in a timedependent manner. Despite fine qualities, using PLGA polymeric nanoparticles for in vivo applications still remains an open challenge due to many factors such as poor stability in water, big diameter (150-200 nm), and the removal of these nanocarriers from the blood stream by the liver and spleen thus reducing the concentration of drugs drastically in tumor tissue. Polyethylene glycol (PEG) is the most used polymers for drug delivery applications and the first PEGylated product is already on the market for over 20 years. This is due to its stealth behavior that inhibits the fast recognition by the immune system (opsonization) and generally leads to a reduced blood clearance of nanocarriers increasing blood circulation time. Furthermore, PEG is hydrophilic and able to stabilize nanoparticles by steric and not ionic effects especially in water. PLGA-PEG block copolymer is an emergent system because it can be easily synthesized and it possesses all good qualities of PLGA and also PEG capability so in the last decade it arose as one of themost promising systems for nanoparticles formation, drug loading, and in vivo drug delivery applications. This review will discuss briefly on PLGA-b-PEG synthesis and physicochemical properties, together with its improved qualities with respect to the single PLGA and PEG polymers. Moreover, we will focus on but in particular will treat nanoparticles formation and uses as new drug delivery system for nanomedical applications.
机译:在过去的几十年中,已经研究了许多合成聚合物用于纳米医学的应用,尤其是作为药物输送系统。为此,聚合物必须是无毒的,可生物降解的和生物相容的。聚乳酸-乙醇酸共聚物(PLGA)是最受研究的聚合物之一,因为它具有完全的生物降解能力,并且具有自组装成纳米胶束的能力,该胶束能够捕获药物等小分子并以时间依赖性的方式释放到体内。尽管质量优良,但是由于许多因素,例如在水中的稳定性差,直径大(150-200 nm),以及肝脏从血流中去除这些纳米载体,将PLGA聚合物纳米颗粒用于体内应用仍然是一个开放的挑战。和脾脏,从而大大降低了肿瘤组织中的药物浓度。聚乙二醇(PEG)是用于药物递送应用的最常用的聚合物,并且首个PEG化产品已投放市场20多年。这是由于其隐身行为抑制了免疫系统的快速识别(调理作用),通常会导致纳米载体血液清除率降低,从而延长血液循环时间。此外,PEG是亲水的并且能够通过空间效应而不是离子效应来稳定纳米颗粒,尤其是在水中。 PLGA-PEG嵌段共聚物是一种新兴的体系,因为它易于合成,并且具有PLGA的所有优良品质以及PEG的功能,因此在过去十年中,它已成为纳米颗粒形成,载药量和体内最有希望的体系之一药物输送应用。本文将简要讨论PLGA-b-PEG的合成和理化性质,以及相对于单一PLGA和PEG聚合物的改良质量。此外,我们将专注于但尤其将处理纳米颗粒的形成并将其用作纳米医学应用的新药物递送系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号